Bioactivity | PNB-001 is an orally active CCK2 selective ligand and antagonist. PNB-001 has anti-inflammatory and analgesic activities[1]. |
Target | CCK2 |
Invitro | PNB-001 (100 nM,30 分钟) 可阻断 CCK4 和 CCK5 诱导的大鼠十二指肠收缩[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> PNB-001 相关抗体: |
In Vivo | PNB-001 (5 和 20 mg/kg,口服) 具有抗炎活性,并能保护大鼠免受吲哚美辛 (HY-14397) 引起的溃疡[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
CAS | 1528760-09-9 |
Formula | C18H16ClNO2 |
Molar Mass | 313.78 |
Appearance | 固体 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
Reference | [1]. Lattmann E, et al. Cholecystokinin-2/gastrin antagonists: 5-hydroxy-5-aryl-pyrrol-2-ones as anti-inflammatory analgesics for the treatment of inflammatory bowel disease. Medchemcomm. 2017 Feb 17;8(3):680-685. |